BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7166752)

  • 21. Detection of antibodies to Chang liver cell in sera from patients with chronic liver diseases by 125I-labelled protein A binding assay and the effect of prednisolone and 6-mercaptopurine treatment on the level of the antibodies.
    Inagaki Y; Morizane T; Matsumura S; Kawamura N; Watanabe T; Kumagai N; Nakamura T; Tsuchimoto K; Tsuchiya M
    Clin Exp Immunol; 1984 Jul; 57(1):79-84. PubMed ID: 6540149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to collagen in patients with chronic liver diseases.
    Menzel EJ; Smolen JS; Renner F; Steffen C; Horak W
    Int Arch Allergy Appl Immunol; 1980; 63(4):425-30. PubMed ID: 7429654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic membrane antibodies: studies of prevalence and specificity.
    Lee WM; Martin KL; Shelton LL; Galbraith RM
    Clin Exp Immunol; 1985 Dec; 62(3):715-23. PubMed ID: 3910322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
    Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver membrane autoantibodies: methods for their detection and clinical significance.
    Nagai S; Manns M; Meyer zum Büschenfelde KH
    Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.
    Djoumerska IK; Tchorbanov AI; Donkova-Petrini VD; Pashov AD; Vassilev TL
    Eur J Haematol; 2005 Feb; 74(2):101-10. PubMed ID: 15654899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of surface expression for the B-cell autoepitope of cytochrome P450 IID6 evidenced by flow cytometry.
    Trautwein C; Gerken G; Löhr H; Meyer zum Büschenfelde KH; Manns M
    Z Gastroenterol; 1993 Apr; 31(4):225-30. PubMed ID: 7684170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune phenomena in liver diseases].
    Berg PA; Klein R
    Z Rheumatol; 1987; 46 Suppl 1():52-60. PubMed ID: 3326362
    [No Abstract]   [Full Text] [Related]  

  • 29. [Humoral and cell-mediated immunity in the comparison of autologous hepatocytes in chronic active viral and autoimmune hepatitis].
    Mazzetti M; Zunarelli P; Cicognani G; Tisselli N; Pignatelli M; Baldini R; Pirillo L; Stefanini GF
    G Clin Med; 1982 Oct; 63(10):678-87. PubMed ID: 6985033
    [No Abstract]   [Full Text] [Related]  

  • 30. Occurrence of antibody against rat hepatic sinusoidal endothelial cells in sera of patients with autoimmune hepatitis.
    Han K; Hashimoto N; Ikeda Y; Shiratori Y; Kato H; Toda G; Komatsu Y; Yamada H; Tanaka A; Kurokawa K
    Dig Dis Sci; 1995 Jun; 40(6):1213-20. PubMed ID: 7781435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment.
    Itoh Y; Okanoue T; Sakamoto S; Nishioji K; Kashima K; Ohmoto Y
    Am J Gastroenterol; 1995 May; 90(5):777-82. PubMed ID: 7733087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune processes.
    Ann Biol Clin (Paris); 1985; 43(4):443-9. PubMed ID: 4091307
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.
    Manns M; Meyer zum Büschenfelde KH; Hütteroth TH; Hess G
    Clin Exp Immunol; 1980 Nov; 42(2):263-72. PubMed ID: 6781800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence against antibody-dependent cell-mediated cytotoxicity as a possible mechanism of liver cell injury in cystic fibrosis.
    Mondelli MU
    Boll Ist Sieroter Milan; 1987; 66(1):66-9. PubMed ID: 3620122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
    McFarlane BM; Bridger CB; Smith HM; Antonov KA; Naoumov N; Williams R; McFarlane IG
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):615-21. PubMed ID: 8590155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of Liver membrane autoantibodies determined by indirect immunofluorescence.
    Tage-Jensen U; Permin H; Krogsgaard K
    J Clin Pathol; 1982 Mar; 35(3):315-8. PubMed ID: 6802881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunology of chronic active hepatitis.
    Eddleston AL
    Q J Med; 1985 Jun; 55(218):191-8. PubMed ID: 3927390
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoantibodies to isolated human hepatocyte plasma membranes in liver disease. I. Specificity for chronic active hepatitis.
    Swanson NR; Reed WD; Yarred LJ; Bartholomaeus WN; Shilkin KB; Joske RA
    Clin Immunol Immunopathol; 1989 Aug; 52(2):291-304. PubMed ID: 2661064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membranous expression of Lewis Y antigen in clustered hepatocytes in chronic viral, autoimmune, and alcoholic liver diseases but not in biliary diseases.
    Sasaki M; Kono N; Nakanuma Y
    Mod Pathol; 1994 Apr; 7(3):339-46. PubMed ID: 8058706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.